Advertise
Ophthalmology Times® offers custom-designed programs to fit the needs of your brand. By utilizing our omnichannel marketing levers you will have access to our highly engaged audience and receive guaranteed, quality results.
Let's work together - Contact Us!
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%
2
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
3
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
4
Eydenzelt, Celltrion’s biosimilar referencing Eylea, approved in Canada
5



.png)


